Skip to main content
PEPG logo

PepGen Inc.

PEPGNASDAQHealthcareBiotechnology

$2.49Today:- (-)1Y −40.00%

As of Oct 26, 2026 close

Market cap
$172.31M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$1.31$7.80
Volume (live)
-
Avg. volume (3M)
929.82K

PepGen (PEPG) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), PepGen used $81.64M of cash in operating activities and spent $264.00K on capital expenditures. That left free cash flow of −$81.90M.

PepGen Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for PepGen Inc. (PEPG) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Operating Activities
Net Income-89.66-89.98-78.63-69.10-27.28-1.89-1.35
Depreciation & Amortization5.155.250.850.490.180.110.11
Stock Based Compensation10.6111.467.054.761.530.120.00
Change in Working Capital-6.22-5.251.954.512.770.010.30
Change in Accounts Receivable0.000.000.034.18-4.34-0.17-0.11
Change in Accounts Payable-0.940.72-0.37-1.412.510.330.06
Change in Other Working Capital-5.29-4.312.291.734.61-0.150.35
Other Operating Activities-1.51-3.86-0.220.080.200.000.06
Net Cash from Operating Activities-81.64-82.37-69.00-59.27-22.60-1.65-0.89
Investing Activities
Capital Expenditures-0.26-0.50-2.60-3.76-0.50-0.01-0.03
Purchases of Investments-93.97-145.17-29.400.000.000.000.00
Sales/Maturities of Investments79.00108.000.000.000.000.000.00
Net Cash from Investing Activities-15.24-37.67-32.00-3.76-0.50-0.01-0.03
Financing Activities
Common Stock Issued108.3989.260.00114.270.000.002.79
Other Financing Activities-0.41-0.51-0.19-2.07147.667.950.00
Net Cash from Financing Activities107.9888.75-0.19112.19147.667.952.79
Summary
Effect of Forex Changes on Cash-0.02-0.060.29-0.320.030.000.00
Net Change in Cash11.09-31.35-100.9048.86124.596.291.88
Cash at Beginning of Period50.9782.32183.23134.379.783.491.61
Cash at End of Period62.0650.9782.32183.23134.379.783.49
Free Cash Flow-81.90-82.87-71.60-63.02-23.10-1.66-0.91
Supplemental Disclosures
Income Taxes Paid-0.072.70----

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About PepGen Cash Flow

What is PepGen's free cash flow?

PepGen had negative free cash flow of $81.90M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$81.64M minus $264.00K of capital expenditures.

How much does PepGen spend on capital expenditures?

PepGen spent $264.00K on capital expenditures in fiscal 2025, compared with $497.00K a year earlier.

Does PepGen pay dividends or buy back shares?

PepGen's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition